Literature DB >> 33477506

The Mutation Spectrum of Maturity Onset Diabetes of the Young (MODY)-Associated Genes among Western Siberia Patients.

Dinara E Ivanoshchuk1,2, Elena V Shakhtshneider1,2, Oksana D Rymar2, Alla K Ovsyannikova2, Svetlana V Mikhailova1, Veniamin S Fishman1, Emil S Valeev1, Pavel S Orlov1,2, Mikhail I Voevoda1.   

Abstract

Maturity onset diabetes of the young (MODY) is a congenital form of diabetes characterized by onset at a young age and a primary defect in pancreatic-β-cell function. Currently, 14 subtypes of MODY are known, and each is associated with mutations in a specific gene: HNF4A, GCK, HNF1A, PDX1, HNF1B, NEUROD1, KLF11, CEL, PAX4, INS, BLK, KCNJ11, ABCC8, and APPL1. The most common subtypes of MODY are associated with mutations in the genes GCK, HNF1A, HNF4A, and HNF1B. Among them, up to 70% of cases are caused by mutations in GCK and HNF1A. Here, an analysis of 14 MODY genes was performed in 178 patients with a MODY phenotype in Western Siberia. Multiplex ligation-dependent probe amplification analysis of DNA samples from 50 randomly selected patients without detectable mutations did not reveal large rearrangements in the MODY genes. In 38 patients (37% males) among the 178 subjects, mutations were identified in HNF4A, GCK, HNF1A, and ABCC8. We identified novel potentially causative mutations p.Lys142*, Leu146Val, Ala173Glnfs*30, Val181Asp, Gly261Ala, IVS7 c.864 -1G>T, Cys371*, and Glu443Lys in GCK and Ser6Arg, IVS 2 c.526 +1 G>T, IVS3 c.713 +2 T>A, and Arg238Lys in HNF1A.

Entities:  

Keywords:  GCK; HNF1A; HNF1B; HNF4A; MODY; diabetes mellitus; maturity onset diabetes of the young; multiplex ligation-dependent probe amplification; next-generation sequencing; population; single-nucleotide variant

Year:  2021        PMID: 33477506      PMCID: PMC7831070          DOI: 10.3390/jpm11010057

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  54 in total

1.  Maturity-onset diabetes of the young (MODY): how many cases are we missing?

Authors:  B M Shields; S Hicks; M H Shepherd; K Colclough; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2010-05-25       Impact factor: 10.122

2.  Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.

Authors:  Elizabeth B Tatsi; Christina Kanaka-Gantenbein; Andreas Scorilas; George P Chrousos; Amalia Sertedaki
Journal:  Pediatr Diabetes       Date:  2019-11-10       Impact factor: 4.866

3.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

4.  High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.

Authors:  O Massa; F Meschi; A Cuesta-Munoz; A Caumo; F Cerutti; S Toni; V Cherubini; L Guazzarotti; N Sulli; F M Matschinsky; R Lorini; D Iafusco; F Barbetti
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

5.  The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

Authors:  B M Shields; T J McDonald; S Ellard; M J Campbell; C Hyde; A T Hattersley
Journal:  Diabetologia       Date:  2012-01-05       Impact factor: 10.122

Review 6.  MODY: history, genetics, pathophysiology, and clinical decision making.

Authors:  Stefan S Fajans; Graeme I Bell
Journal:  Diabetes Care       Date:  2011-08       Impact factor: 19.112

7.  Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes?

Authors:  Inés Urrutia; Rosa Martínez; Itxaso Rica; Idoia Martínez de LaPiscina; Alejandro García-Castaño; Anibal Aguayo; Begoña Calvo; Luis Castaño
Journal:  PLoS One       Date:  2019-07-31       Impact factor: 3.240

8.  L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic β-cells.

Authors:  Jaeyong Cho; Yukio Horikawa; Mayumi Enya; Jun Takeda; Yoichi Imai; Yumi Imai; Hiroshi Handa; Takeshi Imai
Journal:  Commun Biol       Date:  2020-09-08

9.  Identification and functional analysis of GCK gene mutations in 12 Chinese families with hyperglycemia.

Authors:  Zhixin Wang; Chengming Diao; Yijing Liu; Mingmin Li; Jia Zheng; Qian Zhang; Miao Yu; Huabing Zhang; Fan Ping; Ming Li; Xinhua Xiao
Journal:  J Diabetes Investig       Date:  2019-02-01       Impact factor: 4.232

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more
  3 in total

Review 1.  Environmental Factors and the Risk of Developing Type 1 Diabetes-Old Disease and New Data.

Authors:  Katarzyna Zorena; Małgorzata Michalska; Monika Kurpas; Marta Jaskulak; Anna Murawska; Saeid Rostami
Journal:  Biology (Basel)       Date:  2022-04-16

2.  Precision Therapy for a Chinese Family With Maturity-Onset Diabetes of the Young.

Authors:  Juyi Li; Meng Shu; Xiufang Wang; Aiping Deng; Chong Wen; Juanjuan Wang; Si Jin; Hongmei Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-05       Impact factor: 5.555

3.  Case Report: A Novel ABCC8 Variant in a Chinese Pedigree of Maturity-Onset Diabetes of the Young.

Authors:  Chaoyan Tang; Liheng Meng; Ping Zhang; Xinghuan Liang; Chaozhi Dang; Hui Liang; Junfeng Wu; Haiyun Lan; Yingfen Qin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.